MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    FL-41 Lenses for the Treatment of Meige Syndrome

    A. Vickers, A. Lee, T. Campbell (Las Vegas, NV, USA)

    Objective: A case report demonstrating successful treatment of Meige syndrome with FL-41 rose-tinted lenses. Background: Meige syndrome is a rare disorder characterized by blepharospasm and…
  • MDS Virtual Congress 2020

    No pathogenic mutations in HPCA in Chinese dystonia patients

    J. Ma, Y.M Liu (Jinan, China)

    Objective: To explore the frequency and spectrum of HPCA mutation in Chinese subjects with dystonia. Background: Dystonia is known as a group of clinically and etiologically…
  • MDS Virtual Congress 2020

    Writer’s Cramp Dystonia during increasingly complex motor task: analysis of behavior and task fMRI

    N. Bukhari-Parlakturk, A. Michael, M. Derezinski-Choo, J. Voyvodic, S. Davis, N. Calakos (Durham, NC, USA)

    Objective: To evaluate the relationship between clinical features of dystonia and striatal BOLD activity. Background: Dystonia is a brain disorder which causes involuntary twisting movements, abnormal…
  • MDS Virtual Congress 2020

    Stimulation induced dystypia after pallidal deep brain stimulation

    J. Wong, M. Armstrong, L. Almeida, M. Okun, I. Malaty (Gainesville, FL, USA)

    Objective: _ Background: Typing on a keyboard requires complex collaboration between visuospatial procedural memory, language and motor function [1,2]. The impaired ability to type, independent…
  • MDS Virtual Congress 2020

    Weeding Through the Haze: A Survey on Cannabis Use Among People with Parkinson’s Disease

    M. Feeney, B. Kluger, A. Stoessl, D. Bega, S. Gilbert, A. Hosang, E. Ogren, K. Schroeder, C. Evers, J. Beck (New York, NY, USA)

    Objective: To identify themes in cannabis use among people with Parkinson’s disease to inform medical recommendations and the design of future clinical trials. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Demographic characteristics of in-hospital deaths among patients with Parkinson’s disease

    O. Phillips, Z. Kunicki, U. Ackbar, R. Jones, A. D’Abreu, J. Friedman (Providence, RI, USA)

    Objective: Examine demographic characteristics of patients diagnosed with Parkinson's disease who die in hospital by secondary analysis of the National Inpatient Sample. Background: As a…
  • MDS Virtual Congress 2020

    Prion disease with 8 octapeptide repeat insertional mutation presenting with HDL1 phenotype

    C. Cooper, D. Hall, B. Fogel, H. Lee, U. Diseases Network (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a patient with an insertion of 8 extra octapeptide repeats in the prion protein gene (PRNP).…
  • MDS Virtual Congress 2020

    Performance at the Category-Exemplars language test (CATEX) in Parkinson’s disease and Huntington’s disease Italian population

    R. Biundo, T. Gandolfi, M. Garon, E. Fiorenzato, G. Arcara, C. Jaquemont, P. Bisiacchi, C. Semenza, A. Antonini (Venice-Lido, Italy)

    Objective: This study aims to explore CATEX sensitivity to detect early cognitive deficits in Huntington’s disease (HD) and Parkinson’s disease (PD) Italian population. Background: PD…
  • MDS Virtual Congress 2020

    Burden of Huntington’s disease (HD) on loss of employment status and its association with disease stage

    J. Ko, X. Lu, A. Exuzides, R. Fuller, J. Luo (South San Francisco, CA, USA)

    Objective: To evaluate the impact of HD on patients’ employment status and understand its association with disease stage. Background: Work disability is an important outcome…
  • MDS Virtual Congress 2020

    Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease

    P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

    Objective: To identify when white matter connections first begin to degenerate in HD and which connections are most susceptible to early degeneration. Background: Huntington’s disease…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley